Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene editing for hemophilia A with improved factor VIII expression

Gene editing for hemophilia A with improved factor VIII expression

US Patent 11529427 · Granted Dec 20, 2022

Estimated economic value: $51,122,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Base editing enzymes2025
Compositions and methods for gene editing by targeting transferrin2025
Class II, type V CRISPR systems2024
Gene editing for hemophilia A with improved factor VIII expression2024
Class II, type V CRISPR systems2023
Red blood cell targeted factor VIII and method of using the same2021
Method of creating a watertight basement stairway simultaneously with forming a 2005
Cleansing compositions2003
Cleansing compositions2001
Cleansing compositions2001